REGULATIONS 27
classification is adopted then article 15 (substances classified as CMR substances) of Regulation (EC) No 1223/2009 will apply and the Scientific Committee on Consumer Safety will need to consider the overall exposure to zinc pyrithione from both cosmetic and non-cosmetic sources and take into account their effect on vulnerable population groups. The Scientific Committee on Consumer Safety has not considered aggregate exposure in any of their previous opinions on zinc pyrithione.
SCCS/1594/18 – Phenylene Bis- Diphenyltriazine
The Scientific Committee on Consumer Safety has concluded that phenylene bis- diphenyltriazine is safe to use as a UV filter in sunscreen products up to a maximum concentration of 5%. Because of the insoluble nature of phenylene bis- diphenyltriazine and the lack of safety data for exposure to it by inhalation the opinion applies only to dermal use and not to products which may be inhaled into the lungs. As phenylene bis-diphenyltriazine may contain impurities such as N-methyl- pyrrolidone and hydrazine which are classified as CMR 1B the Scientific Committee on Consumer Safety have recommended that these should be present only at trace levels.
SCCS/1595/18 – Styrene/Acrylates Copolymer and Sodium Styrene/Acrylates Copolymer (nano)
Article 16 of Regulation (EC) No 1223/2009 requires that any product containing nanomaterials be notified to the European Commission six months before it is placed on the market. If there are any concerns over the safety of the nanomaterial then the Commission will ask the Scientific Committee on Consumer Safety to carry out a risk assessment. The European Commission has received eight notifications for cosmetic products containing styrene/acrylates copolymer and sodium styrene/acrylates copolymer in nano form. The Scientific Committee on Consumer Safety was asked to consider the safety of the nanomaterials styrene/acrylates copolymer and sodium styrene/acrylates copolymer when used in leave-on cosmetic products at a maximum concentration of 0.06%. When the Scientific Committee on Consumer Safety looked at these nano materials it turned out that they consisted of a “(nearly) finished product consisting of a nanomaterial shell (Nanosphere 100) and encapsulated active ingredients (Theophyllisilane C and Algisum C2 (SA) methylsilanol mannuronate).”2
The Scientific
Committee on Consumer Safety were unable to reach an opinion on the safety of
styrene/acrylates copolymer and sodium styrene/acrylates copolymer in nano form due to insufficient data.
SCCS/1596/18 – Colloidal Silver (nano) The Scientific Committee on Consumer Safety was asked to consider the safety of nanomaterial colloidal silver when used at a maximum concentration of 1% in cosmetic products including toothpaste and skin care products. Due to the lack of sufficient data the Scientific Committee on Consumer Safety was unable to give an opinion on the safety of colloidal silver in nano form when used in oral and dermal cosmetic products.
SCCS/1600/18 - Climbazole The Scientific Committee on Consumer Safety and the committees which preceded it have looked at the safety of climbazole on a number of occasions. Previous opinions had concluded that climbazole was safe for human health when used up to a maximum concentration of 2% as an anti-dandruff agent in rinse–off shampoos and 0.2% as a preservative in leave–on products (face cream, hair lotion, foot care) with the exception of cosmetic products applied to the full body (body lotion).3
The most recent
opinion SCCS/1600/18 looked at whether climbazole was safe to be used as a preservative in rinse-off shampoos at a
The Dawn of a Better Emulsifier in-cos Global, Stand F120 — Suppliers’Day N ewYo
York, Stand 818
BENEFIT S Low Cost PEG-Free
Liquid Crystal Structure Easy to Handle Particles Botanically Derived
PEG-Free
Low-Cos Natural G
- st FU UNCTIONS
Improve Sensory Appeal Achieve T argetViscosity Improve Skin Hydration Decrease TEWL
www.floratech.com ®
Product Info April 2019
PERSONAL CARE EUROPE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188
